PatientMatch — Privacy-first clinical trial discovery

32 trials

Hidradenitis SuppurativaRecruiting now

Enrolling now24

Nationwide

A 16-Week Study to Learn About Ritlecitinib for Hidradenitis Suppurativa

Pfizer

Ph 2·~17mo·4 sites in CA, IN, MI +1

Enrolling now

5q~2min

Check if I qualify View study

Nationwide

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Novartis Pharmaceuticals

Ph 3·~4yr·36 sites in AL, AZ, CA +15

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Phase 3 Trial of Remibrutinib for Hidradenitis Suppurativa

Novartis Pharmaceuticals

Ph 3·~4yr·36 sites in AR, AZ, CA +18

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

AbbVie

Ph 3·~5yr·87 sites in AL, AR, AZ +25

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

Navigator Medicines, Inc.

Ph 2·10 sites in AZ, FL, KY +2

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

UCB Biopharma SRL

Ph 3·~4yr·12 sites in AZ, CA, DC +6

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Sanofi

Ph 2·~2yr·9 sites in AZ, CA, FL +2

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

VELA-TEEN Trial

MoonLake Immunotherapeutics AG

Ph 3·~15mo·18 sites in AR, CA, DC +11

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Brivekimig Trial for Hidradenitis Suppurativa

Sanofi

Ph 2·~2yr·11 sites in CA, FL, GA +6

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Feasibility Study on Radiofrequency-Based Selective Electrothermolysis

Johns Hopkins University

Device·~11yr·1 site in MD

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

EVO101 Topical Cream for Hidradenitis Suppurativa

Virginia Clinical Research, Inc.

EARLY_Ph 1·~6mo·1 site in VA

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

Povorcitinib Trial for Hidradenitis Suppurativa

Incyte Corporation

Ph 2·~2yr·23 sites in AL, AZ, CT +14

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

The Safety and Efficacy of Roflumilast Foam in HS

Beth Israel Deaconess Medical Center

Ph 2·~3yr·1 site in MA

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)

Wynn Medical Center

Device·Ph 1·~16mo·1 site in CA

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

Bluefin Biomedicine, Inc.

Ph 2/3·~1.5yr·31 sites in AZ, CA, FL +15

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

AbbVie

Ph 3·~3yr·73 sites in AL, AR, AZ +24

Enrolling now

4q~2min

Check if I qualify View study

Nationwide

An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa

University of Alabama at Birmingham

EARLY_Ph 1·~2yr·1 site in AL

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

Aviclear Trial for Hidradenitis Suppurativa

University of Miami

Device·~13mo·1 site in FL

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

University of Minnesota

EARLY_Ph 1·~3yr·1 site in MN

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

Milton S. Hershey Medical Center

Ph 2·~5yr·1 site in PA

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Pelashield™ PainGuard™ vs Restrata® in HS Surgery

Rutgers, The State University of New Jersey

Device·~10mo·1 site in NJ

Enrolling now

16q~4min

Check if I qualify View study

Nationwide

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

AbbVie

Ph 2·~3yr·2 sites in CA, MI

Enrolling now

5q~2min

Check if I qualify View study

Nationwide

A Study on Bimekizumab in Breast Milk

UCB Biopharma SRL

Ph 1·~18mo·4 sites in CA, FL, NC +1

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

Rollover Trial for Povorcitinib

Incyte Corporation

Ph 3·~3yr·107 sites in AL, AR, AZ +24

Enrolling now

8q~2min

Check if I qualify View study